'Designer drugs': update on the management of novel psychoactive substance misuse in the acute care setting
- PMID: 25099844
- PMCID: PMC4952836
- DOI: 10.7861/clinmedicine.14-4-409
'Designer drugs': update on the management of novel psychoactive substance misuse in the acute care setting
Abstract
The use of novel psychoactive substances ('legal highs' or 'designer drugs') is increasing worldwide. Patients misusing such substances have been reported to experience severe or prolonged side effects requiring admission to acute or critical care wards. These complications can be life threatening if misdiagnosed or mismanaged. As physicians have traditionally had less involvement with the management of such patients compared with their colleagues in emergency departments an update in the management of such patients is indicated. Here we present a summary of the management of those novel substances with the potential for serious complications based on a review of current literature.
Keywords: Complications; designer drugs; legal highs; management; novel psychoactive substances.
© 2014 Royal College of Physicians.
References
-
- Home Office Drug misuse: findings from the 2012/13 Crime Survey for England and Wales. London: Home Office, 2013. www.gov.uk/government/publications/drug-misuse-findings-from-the-2012-to... [Accessed 6 June 2014].
-
- European Monitoring Centre for Drugs and Drug Addiction European drug report 2013: trends and developments. Lisbon: EMCDDA, 2013. www.emcdda.europa.eu/publications/edr/trends-developments/2013 [Accessed 6 June 2014]. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials